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Summary: The ES 600 sample^selective multibatch analyser was subjected to a multicentre evaluation in six
laboratories in accordance with ECCLS guide-lines. During the 3-month trial, five Enzymun-Test® diagnostics
(T4, TBG, Digoxin, CEA and TSH)') were measured at 25 °C.
The study yielded the following results:
1. The within-series and between-series precision were very good, with mean CV's of approx. 3% and 7%
respectively.
2. Recovery of the target values for three control sera was in the range ±5%.
3. A trend in measurements did not occur in any of the methods investigated (for series of over 240
determinations).
J) T4 = tfcyroxine, TBG = thyroxine binding globulin, CEA = carcinoembryonic antigen, TSH = thyrotropin.
J. Clin. Chem. Clin. Biochem. / Vol. 26,19&8 / No. 3
150 Knedel et al.: Multicentre study: ES 600 Enzymun-Test® System
4. Comparison of the results with those obtained on the ES 22 Enzymun-Test® system showed good agreement.
5. Within the measuring range defined by the standards, no deviations could be ascertained upon dilution of
the samples.
6. Total carry-over in the instrument was below 0.05%.
From studies with instruments from the first production series, it became evident that modifications were
necessary to improve the reliability. A follow-up measuring programme confirmed a clear improvement in
reliability and a reduction in the imprecision, particularly for results from series to series.
Introduction
The proportion of determinations in the clinical chem-
istry laboratory based on immunochemical methods
is continually increasing. Because of the problems
associated with radioimmunoassays (special equip-
ment, disposal of waste), the various enzyme-immu-
noassays are becoming more important. In addition
to the rising number of determinations, however, in-
creasingly strict requirements are being placed on the
reproducibility of the results in order to meet the
increasing demands, for example in following the
course of tumours via long-term monitoring with ap-
propriate tumour markers. This makes mechanisation
of such procedures necessary.
The first step towards a partially mechanized instru-
ment was made with the ES 22 (1). The ES 600 now
available is a fully mechanized instrument which
meets all requirements.
The ES 600 system, the instrument together with the
corresponding enzyme-immunoassays, was subjected
to a multicentre trial in six laboratories in accordance
with the recommendations of the ECCLS (2). The
goal of the study was the verification of the function
of the instrument by comparison with another mech-
anized procedure for the performance of Enzymun-
Test® methods, which has already been investigated
against manual techniques.
Description of the ES 600
Enzymun-Test® System ES 600 (ES 600) is a fully mechanized
instrument for carrying out, measuring, evaluating and docu-
menting heterogeneous enzyme-immunoassays, in particular
those methods based on coated tube technology (ELJSA). In
addition, turbidometric assays can also be carried out on the
instrument.
The ES 600 is a sample-selective multibatch analyser with a
modular construction. Within a single run, the instrument car-
ries out up to 15 tests (freely selectable by the user) on up to
150 samples, using up to 600 coated tubes without involvement
of the user.
Details of the instrument specifications based on the IFCC
guidelines (3, 4) are given in table 1.
Tab. 1. Specification of the ES 600 Enzyniun-Test® System
according to the guide-lines of the IFCC (3, 4).
1. Type Sample-selective multibatch analyser.
2. Testing Enzymun-immunoassay, turbidimetric im-
procedure munoassays.
Evaluation via non-linear calibration curves.
A choice of 4 curve functions is available for
making the evaluation.
3. Throughput Work cycle 11s. Up to 650 working steps per
hour (via parallel procedures).
The throughput is dependent upon the nun>
ber of samples, incubation times, methods
used and length of series.
4. Samples Sample transport: sample rotor with 150 po-
sitions for samples and standards together
with ail additional 10 positions for control
sera.
Sample vessels, graduated plastic vessels, ti-
lizable volume 2.0 ml.
Dispensing: dispensing syringe driven by step-
ping motor.
Sample volumes: 5—200 μΐ; selectable in 1 μΐ
increments by the user.
5. Reagents Transport: reagent rotor with 15 positions; up
to 4 reagents per method can be used.
Reagent vessels: 150 ml plastic vessels with
"chicken-feed" delivery system.
Dispensing: 2 diluters driven by stepping mo-
tors.
Reagent volumes: 400 — 1000 μΐ; selectable in
1 μΐ increments by the user.
6. Procedure Incubation: Time-controlled incubation; du-
ration between 5 min and 18 hours selectable
in l min increments by the user.
Temperature control: Temperature of liquid
flow in incubator and cuvette holder regulated
by Peltier elements; temperature selectable be-
tween 25 and 30 °C by the user.
Temperature constancy: ± 0.3 °C
Reaction vessels: one coated tube for each test.
Mixing: non-invasive mixing after every dis^
pensing operation and prior to photometric
measurements.
Washing unit: for bound/free 'separation by
rinsing out the tubes with the rinsing solution.
The intensity of the washing step is test-spe-
cifically selectable.
Measurement: end-point measurement against
blank.
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Tab. 1. Continued
7. Photometer Single beam photometer with reference detec-
tor for stabilizing the light intensity.
Light source: Halogen lamp
Wavelength range: 360—750 nm
Selection via IR-blocked interference filter in
a filter wheel with 4 positions + 1 dark cur-
rent position.
Standard equipment: filter 422 ± 1 nm.
Half-band width < 4 nm.
Linearity —0.1 — 1 A (with reference to a
path length of 3 mm.
Imprecision: within-series CV < 0.5%.
Cuvette: flow-through cuvette made of fused
silica.
Path length: 3 ± 0.01 mm
Volume: 16 μΐ
8. Data Computer (Professional 350 from Digital
processing Equipment) for instrument control and data
processing.
Interface V24
Input via keyboard and VDU
Output via LA 50 Printer from Digital Equip-
ment.
9. Storage Diskette with storage possibilities for a com-
of data plete run together with data on long-term
quality control.
10. Services Only a power supply is required (instruments
can be switched from 110 V/60 Hz to 220 V/
50 Hz).
11. Dimensions ES 600: height: 110 cm
width: 78 cm
length: 118 cm
weight: 250 kg
12. Ambient Temperature: 15—35 °C (temperature drift
conditions < 3 °C/h)
Relative humidity: up to 70% (condensation
must not occur).
Methods
Participants and reagents
Six clinical chemistry laboratories took part in the multicentre
evaluation of the ES 600. Five enzyme-immunoassays were
employed in the investigations. The test-specific properties of
Enzymun-Test® T4 (5, 11), TBG (6, 7), Digoxin (8), TSH (9)
and CEA (10) have already been determined in separate eval-
uations. Data on the instrument settings for measurements
carried out at 25 °C are given in table 2.
Investigations
The testing of the instrument was based on the ECCLS rec-
ommendations for the evaluation of clinico-chemical analysers
(2).
Within-series precision
In order to determine the within-series precision, three control
sera containing the corresponding analytes in differing concen-
trations were used. All six laboratories worked with the same
control materials. In addition, each laboratory prepared three
human serum pools having differing analyte concentrations;
these were also used for the determination of within-series
precision. Each measurement of precision with 20 duplicate
determinations was carried out twice.
Between-series precision
In order to determine the between-series precision, duplicate
determinations were carried out twice daily on three control
sera for 10 days. The same procedure was carried out with two
human serum pools prepared in the respective laboratories.
Lvaluation was always made using the second value obtained.
Trend in measurements
In at least 5 series, the complete group of standards was again
determined at the end of the series, and the absorbances com-
pared with those obtained at the beginning of the series; in
addition, a standard curve was calculated from the results each
time.
Method comparison
In order to rule out effects due to reagent differences, about 80
human sera were determined in parallel with the same reagents
on the ES 600 and the ES 22 (1) using duplicate determinations.
The same sera were also determined using the routine method
of the respective laboratory.
Linearity
Each laboratory prepared a ΙΟ-step dilution series from a hu-
man serum with a high analyte content and a human serum
with a low analyte content. This procedure was carried out for
all five analytes. The dilutions were measured in series using
two duplicate determinations each time.
Carry-over
The carry-over experiments were carried out in such a way that
three duplicate determinations of a human serum with the
highest possible analyte concentration were followed by three
duplicate determinations of a serum having a low concentra-
tion. This sequence was measured ten times successively within
a series.
Tab. 2. Instrument adjustment data for Enzymun-Test® parameters on the ES 600 at an incubation temperature of 25 °C.
Analyte Type of Test Sample volume Reagent volume Intensity of
(μΐ) (ml) washing
Time of incubation
Thyroxine
Thyroxine binding globulin
Digoxin
Thyrotropin
Carcinoembryonic antigen
competitive
competitive
competitive
2-step-sandwich
1 -step-sand wich
20 1
50 1
100 1
200 1
100 1
9
6
4
6
6
30/25 min
30/25 min
25/20 min
60/60/45 min
120/45 min
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Results and Discussion
Within-series precision
The results are given in table 3 and for the measured
human serum pools in figures 1 — 5.
Mean coefficients of variation of 3% were found over
the entire measuring range for the competitive meth-
ods for thyroxine (T4) (fig. 1), thyroxine binding glob-
ulin (TBG) (fig. 2) and digoxin (fig. 3). Also in the
lower and higher measuring ranges, no values were
found above 8.5% for thyroxine, 6.4% for thyroxine
binding globulin and 8.0% for digoxin.
For the determinations based on the sandwich prin-
ciple, i.e. carcinoembryonic antigen (CEA) (fig. 4)
and thyrotropin (TSH) (fig. 5), the coefficient of var-
iation showed a greater dependence on the concen-
tration of the sample measured; this was due to the
large measuring range and the position of the cali-
bration curve. As this effect only becomes manifest
in the lower range, the mean coefficients of variation
are generally about 2% for carcinoembryonic antigen
and 5% for thyrotropin. Coefficients of variation of
20% were only found in samples containing the an-
alyte in the lower concentration range in the vicinity
of the method detection limit in individual series.
Between-series precision
The results are summarized in table 4 and presented
graphically in figures 6—10 for the human serum
pools measured.
Here, too, the competitive methods show only a slight
dependence upon concentration. For thyroxine (fig.
6) the mean CV is 7%, with the values from all of
the laboratories involved being below 10%.
Thyroxine binding globulin measurements in human
serum pools (fig. 7) yielded a mean CV of 7% al-
though three values were distinctly higher (up to
15%). For digoxin (fig. 8), the mean CV was 6%
whereas in human serum pools values of up to 17%
were obtained at the lower detection limit.
For the thyrotropin and carcinoembryonic antigen
protein determination used within the framework of
the multicentre study, a greater concentration^-
pendence of the between-series imprecision was meas-
ured. For carcinoembryonic antigen (fig. 9), the mean
value is 7% (with the very good precision in the higher
measuring range contributing to this), whereas in the
lowest measuring range the CV is up to 16%. One
serum pool was considerably above the measuring
range of the method (50 g/l). The concentration-
Tab. 3. Within-series precision.
The range of coefficients of variation gives the lowest and highest value obtained each time.
Enzymun-Test®
N*
Concentration ^g/dl)
Median of CV (%)
Range of CV (%)
TBG
N
Concentration (mg/1)
Median of CV (%)
Range of CV (%)
Digoxin
N
Concentration ^g/l)
Median of CV (%)
Range of CV (%)
CEA
N
Concentration ( g/l)
Median of CV (%)
Range of CV (%)
TSH
N
Concentration (mU/1)
Median of CV (%)
Range of CV (%)
Precinorm®-IM
12
8.3
4.6
3.1-6.6
12
14.5
3.3
2.1-5.2
12
0.90
4.4
3.0-8.0
12
6.0
2.3
1.5-4.6
11
3.3
4.1
3.0-6.2
Precipath®-IM
12
15.9
4.1
2.9-6.7
12
28.8
2.4
1.3-4.3
12
3.36
2.1
1.4-2.8
12
51.8
1.6
0.7-2.8
10
9.9
2.7
1.8-6.4
Pack
control
12
8.6
4.3
2.8-6.7
11
16.9
3.2
1.9-6.3
12
2.0
3.0
1.7-3.9
11
11.5
1.9
1.3-6.3
11
5.3
5.0
1.6-8.8 °
Human
serum
low
6
< 5
4.9
2.7-8.8
7 <15
3.4
2.3-4.0
8
< 1
4.4
3.0-5.6
14
< 3
6.5
2.3-21.8
16
< 4
10.3
2.7-21.2
Human
serum
intermediate
16
5 -11
3.5
2.5- 6.4
13
15 -25
2.9
1.7- 5.2
9
1 -2
3.3
1.9-4.5
6
3 -25
1.7
0.9- 2.9
6
4 -20
6.7
1.4- 9.6..
Human
serum
high
12
>11
4.1
2.7-8.4
8
>25
1.8
1.1-6.4
11
> 2
2.4
1.6-4.1
9
>25
1.7
0.9-2.3
9
>20
2.5
1.4-5.0
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Fig. 1. Within-series precision for Enzymun-Test® T4
The precision profile shows all measurements obtained
from human serum pools in the participating labora-
tories.
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8
6
>^ 4
2
-
-
*. +
-β + A °
A
 o ^* · +Θ Α ·0 +/q
I 1 — - 1
1 2 3
Digoxin Ιμς/Ι]
0 2.5
Digoxin Inmoi/l]
1
4
§
5
Fig. 3." Within-series precision for Enzymun-Test® Digoxin
For explanation and symbols see figure 1.
5 -*
10 20 30
Carcinoembryonic antigen
40 50
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Fig. 5. Within-series precision for Enzymun-Test® TSH
For explanation and symbols see figure 1.
40
dependency in the thyrotropin test (fig. 10) is some-
what more clear. In the lower measuring range, the
CV's are above 10% with the individual values gen-
erally differing considerably. Here too, however, for
values above 4 mU/1 the coefficients of variation are
on average around 5%.
Collaborative study
Within the scope of the determination of between-
series precision, control sera (Precinorm® IM, Preci-
path® IM and the respective pack controls) were sent
to all of the participating laboratories. The results for
Precinorm® IM are shown in figures 11 — 15; similar
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Tab. 4. Between -series precision.
The range of concentrations and coefficients of variation gives the highest and lowest values determined each time in a
laboratory.
Enzymun-Test®
T
N
Target value fag/dl)
Median of recovery fag/dl)
Range of recoveries fag/dl)
Median of CV (%)
Range of CVs (%)
TBG
N
Target value (mg/1)
Median of recovery (mg/1)
Range of recoveries (mg/1)
Median of CV (%)
Range of CVs (%)
Digoxin
N
Target values fag/l)
Median of recovery fag/l)
Range of recoveries (μ£/ί)
Median of CV (%)
Range of CVs (%)
CEA
Ν
Target values fag/l)
Median of recovery (pg/T)
Range of recoveries (\ig/l)
Median of CV (%)
Range of CVs (%)
TSH
Ν
Target values (mU/1)
Median of recovery (mU/1)
Range of recoveries (mU/1)
Median of CV (%)
Range of CVs (%)
Preci-
norm®-IM
6
8.3
8.5
7.0-9.8
7.0
5.1-9.2
6
14.5
14.9
12.1-18.1
7.9
4.9-10.9
6
0.90
0.98
0.83- 1.16
7.5
3.2-10.4
6
6.0
6-4
4.3- 7.6
7.7
5.2-13.0
6
3.3
3.2
2.3- 5.6
14.2
5.8-23.5
Preci-
path®-IM
6
15.9
16.3
12.3-20.2
8.6
5.4-10.3
6
28.8
28.5
25.7-33.6
5.6
5.2- 7.7
6
3.36
3.57
2.64- 4.07
5.1
3.1-10.0
6
51.8
54.5
48.0-69.5
5.8
2.3-10.5
6
9.9
9.3
7.3-11.2
8.7
3.9-10.4
Pack
Control
6
8.6
8.4
6.7-10.2
6.9
5.6- 9.5
6
16.9
17.4
12.6-21.0
6.7
5.0-10.0
6
2.00
2.01
1.59- 2.67
6.4
2.0-10.2
6
11.5
11.1
8.7-13.5
7.3
4.1-15.2
6
5.3
5.2
3.8- 7.2
8.8
5.0-12.2
Human
serum
low
3
< 5
3.2-4.4
6.6
6.6-8.2
3
<15
10.0-14.2
11.4
9.3-15.6
6
< 1.00
0.59- 0.90
12.4
6.5-17.1
5
< 3
1.3- 2.9
14.6
8.2-15.6
7
< 4
0.5*- 2.6
23.0
12.6 -34.9*
Human
serum
intermediate
• r
6
5 -11
7.5- 9.7
7.2
6.5-10.0
4
15 -25
15.1-19.2
11.7
8.5-15.2
2
1 - 2
1.11- 1.21
10.8
8.3-13.2
3
3 -25
10.5-18.7
5.5
3.2-10.1
2
4 -20
17.8^18.9
3.9
2.7- 5.0
Human
serum
high
3
>11
12.8-14.9
5.8
5.1- 6.3
3
>25
24.4-32.3
4.9
4.2- 5.7
4
> 2
3.03-4.75
4.6
3.3-5.6
3
>25 ·
33.3-164.2*
5.8
4.6- 14.9*
3
>20
24.7-32.9
5.0
4.1- 9.0
* Value out of measuring range
results were obtained for the other control sera. The
presentations contain all of the values found in 10
series in the laboratories.
For thyroxine (fig. 11; target value 8.3 μg/dl), the
median value was 8.5 with a scatter of 7.0-9.0 μg/dl
for the individual values. For thyroxine binding glob-
ulin (fig. 12; target value 14.5 mg/1), the median value
was 14.9 with a scatter of 12.1 — 18.1 for the individual
values. For digoxin (fig. 13; target value 0.9 μ^), the
corresponding figures are 0.98 and 0.83-1.16. The
following were determined for the sandwich assays of
carcinoembryonic antigen and thyrotropin: for car-
cinoembryonic antigen (fig. 14; target value 6.0 μ^/Ι),
a median of 6.4 and a scatter of 4.3-7.6; for thyro-
tropin (fig. 15; target value 3.3 mU/1), a median of
3.2 and a scatter of 2.3 — 5.6 for individual values
from all of the laboratories.
In all laboratories, the individual values show a nor-
mal distribution and only differ slightly from the
common mean.
Measurement trend
Because of the calibration necessary in each ran, the
procedure recommended by the ECCLS was modified
somewhat so that the standards used for calibration
were again employed as samples at the end of lengthy
measurement series.
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Fig. 10. Between-series precision for Enzymun-Test® TSH
For explanation and symbols see figure 1.
As an example figure 16 shows the calibration curves
for the absorbances of the standards at the beginning
and end of the series for Enzymun-Test® T4.
No trend in the measurements can be seen for any of
the methods. The absorbances of the standards at the
beginning and end of the series lie within the meas-
urement tolerances and show no systematic differ-
ences.
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Method comparison
The ECCLS guidelines for the evaluation of analysers
in clinical chemistry recommend that the conditions
for the comparison should be, as far as possible, the
same, i. e. using the same reagents (including stand-
ards). For this reason comparisons with the results
obtained using the procedure on the ES 22 were used
to assess the instruments. As a generality it should be
noted that the precision of determinations using the
ES 22 is not as good as that obtained using the ES
600. The results for the individual tests are given in
tables 5 — 9 for all laboratories and also graphically
(figs 17-21).
Statistical evaluation was made according to the non-
parametric procedure given by Bablok & Passing (12,
13).
The following individual results were obtained:
Enzymun-Test® T4 (fig. 17)
The measurements on the two instruments show very
good agreement. No systematic deviation can be seen.
Enzymun-Test® TBG (fig. 18)
The results basically correspond to those obtained for
thyroxine. No systematic difference can be seen.
Tab. 5. Method comparisons for E
Thyroxine concentration μ,<
un-Test^ T4.
Laboratory
1
2
3
4
5
6
Number of
paired values
50
79
80
80
76
80
X
8.4
8.1
8.0
8.0
7.9
8.3
(Mg/dl)
8.8
8.3
8.4
8.5
7.4
8.2
Range
(Hg/dl)
2.8-17.6
2.8-13.5
4.0-19.5
0.3-15.9
1.1-16.0
4.1-20.1
Bablok & Passing
y = a + bx
y = -2.58 + 1.374x
y = 0.245 + l.OOOx
y = 0.976 + 0.932X
y = -0.122 + 1.083x
y = 0.059 + 0.933x
y = 0.735 + 0.903x
Coefficient of
correlation
0.934
0.851
0.935
0.883
0.963
0.884
Median y = 0.152 + 0.967x 0.909
Tab. 6. Method comparisons for Enzymun-Test® TBG.
β Thyroxine binding globulin concentration mg/1.
Laboratory
1
2
3
4
5
6
Number of
paired values
50
75
80
80
101
80
X
(mg/0
17.3
16.5
14.5
15.1
17.5
14.8
y(mg/1)
17.1
15.7
16.8
15.3
17.5
15.6
Range
(mg/1)
11.0-30.0
6.5-27.0
9.0-28.0
6.0-25.0
9.5-29.0
8.0-29.0
Bablok & Passing
y = a + bx
y = -3.765 + 1.19x
y = 2.639 + 0.788x
y = -3.878 + 1.412x
y = 1.646 + 0.904x
y = 0.790 + 0.947x
y = 2.740 + 0.856x
Coefficient of
correlation
0.954
0.644
0.796
0.919
0.873
0.809
Median 1.218 + 0.926x 0.841
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Tab. 7. Method comparisons for Enzymun-Test® Digoxin.
Digoxin concentration μg/l.
Laboratory
1
2
3
4
5
6
Number of
paired values
78
79
78
79
74
60
X
0.78
1.44
1.66
1.40
1.32
1.10
L/D
0.91
1.41
1.65
1.34
1.36
1.15
Range
0.00-4.48
0.43-6.35
0.26-4.10
0.19-6.48
0.13-5.15
0.00-5.0
Bablok & Passing
y = a -f bx
y = 0.284 + 0.833x
y = -0,023 + 0.980x
y = 0.057 + 0.958x
y = 0.060 + l.OlOx
y = -0.036 + 1.076x
y = 0.238 + 0.791x
Coefficient of
correlation
0.981
. , 0.953
0.968
0.981
0.975
0.905
Median y = 0.058 + 0.939x 0.972
Tab. 8. Method comparisons for Enzymun-Test® CEA.
Carcinoembryonic antigen concentration μ§/1.
Laboratory
1
2
3
4
5
6
Number of
paired values
71
52
79
74
52 · <
78
χ
3.5
2.0
4.0
20.2
14.9
2.6
y
3.4
2.5
3.8
20.5
13.2
3.6
Range
fcg/0
0.5-10.0
0.0- 4.7
0.0-44.0
0.0-60.0
0.5-60.0
0.0-10.0
Bablok & Passing
y = a + bx
y = 0.805 -f 0.750x
y = 0.891 + 0.789x
y = 0.150 + 0.887x
y == 0.868 + 0.967x
y = 0.150 + 0.863x
y = 1.535 + 0.864x
Coefficient of
correlation
0.912
0.763
0.986
0.989
0.985
0.861
Median y = 0.632 + 0.864x 0.949
Tab. 9. Method comparisons for Enzymun-Test® TSH.
Thyrotropin concentration mU/1.
Laboratory Number of χ
paired values (mU/1)
1
2
3
4
5
6
46
80
73
79
64
80
11.9
1.6
6.0
6.9
10.2
2.1
(mU/1)
9.4
1.7
6.1
8.3
10.1
2.2
Range
(mU/1)
1.0-59.0
0.0- 5.0
0.0-51.0
0.0-70.0
0.0-33.0
0.0- 9.0
Bablok & Passing
y = a + bx
y =
y =
y =
y =
y =
y =
-0.549 + 0.808x
0.181 + 0.901x
0.158 + 0.981x
0.239 + l.lOlx
-0.224 -f 0.971x
0.496 + 0.832x
Coefficient of
correlation
0.962
0.634
0.997
0.986
0.994
0.901
Median y = 0.170 + 0.940x 0.975
Enzymum-Test® Digoxin (fig. 19)
In this test also, the results on the ES 22 agree very
well with those obtained on the ES 600.
Enzymum-Test® CEA (fig. 20)
When assessing the results in table 8, the small con-
centration range used in some cases (laboratories 1,
2 and 6) must be taken into account. On the whole,
however, no systematic deviation can be observed here
either.
Enzymum-Test® TSH (fig. 21)
Here, too, the result is influenced by the use of sample
materials in a very narrow measuring range (labora-
tories 2 and 6). The agreement is, however, also very
good.
Linearity/measuring range
This investigation was carried out by blending a hu^
man serum containing a high analyte concentration
with a human serum containing as low an analyte
concentration as possible.
The results are given in figures 22—26. No deviation
within the measuring ranges defined by the standards
were found for any of the methods. As a result of the
measuring conditions (3 mm path length of the cu-
vette) and the excellent linearity of the photometer, it
would have been possible to make measurements over
a greater measuring range; however, interpolation be-
yond „the range defined by the standards cannot be
carried out with non-linear calibrator! curves.
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Fig. 17. Instrument comparison for Enzymun-Test® T4
Comparative measurements were carried out using the
same method on ES 22 Enzymun-Test® System.
Number of paired values: 76
y = 0.059 + 0.933 χ
Coefficient of correlation: 0.963
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Fig. 18. Instrument comparison for Enzymun-Test® TBG
Comparative measurements were carried out using the
same method on ES 22 EnzymunrTest® System.
Number of paired values: 80
y = 1.646 + 0.904 χ
Coefficient of correlation: 0.919
Fig. 20. Instrument comparison for Enzymun-Test® CEA
" Comparative measurements were carried out using the
same method on ES 22 Enzymun-Test® System.
Number of paired values: 74
y = 0.868 + 0.967 χ
Coefficient of correlation: 0.987
Fig. 21. Instrument comparison for Enzymun-Test® TSH
Comparative measurements were carried out using the
same method on ES 22 Enzymun-Test® System,
Number of paired values: 64
y = 0.224 + 0.971 χ
Coefficient of correlation: 0.993
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Fig. 19. Instrument comparison for Enzymun-Test® Digoxin.
Comparative measurements were carried out using the
same method on ES 22 Enzymun-Test® System.
Number of paired values: 78
y = 0.057 + 0.958 χ
Coefficient of correlation: 0.968
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Carry-over
The results are summarized in table 10. In making an
assessment it should be remembered that because of
the measuring range or the physiological range of the
sample concentrations there are in some instances
only very small differences between the "high" and
"low" samples. This directly affects the evaluation
which is based on concentration differences.
For this reason, in table 10 the coefficients of variation
are given for comparison purposes in the low concen-
tration range. It is evident here, that even in the most
unfavourable case (for Enzymun-Test® T4) a calcu-
lated carry-over of 0.6% is still well below the preci-
sion of the method in this measuring range; hence,
no significant alteration of the values determined is
to be expected. It can be concluded from the results
that overall the carry-over is around 0.05% in the ES
600.
Tab. 10. Carry-over on the ES 600.
The procedure is described in the text.
Enzymun-
Test®
T4
TBG
Digoxin
CEA
TSH
X
high
22.2
33.3
13.7
444.3
28.6
X
low
6.2
3.0
0.97
0.8
0.8
Xi
low
6.3
3.1
1.00
0.9
0.9
Carry-over
(%)
high — > low
0.6
0.3
0.2
0.02
0.4
CV (%)
χ low
4
4
4
8
10
1. technical changes to the instrument, and
2. alterations to the user software.
The technical changes to the instrument mainly con-
cern modifications to increase the reliability of instru-
ment function (particularly concerning tube transport
and the wash station). These changes were carried out
immediately. The corrections to the user software
took somewhat more time, but were not decisive for
the reliability of instrument function.
In addition to the less serious defects, the modifica-
tions are mainly related to the installation of a bidi-
rectional interface, which for differently organized
laboratories greatly simplifies and accelerates the nec-
essary input for the RUN definition. In addition to
the normal input via keyboard and display screen, it
is also possible to enter requests for analyses from
patient samples directly via the laboratory electronic
data processing or with the aid of a barcode reader,
thereby substantially shortening the preparation time.
This additionally increases the rationalization effect
by a further saving in laboratory capacity.
The ES 600 instrument provides a further possibility
for lowering analysis costs, namely by carrying out
determinations as single analyses and employing re-
calibration with only one standard in association with
stored calibration curves. From the present evaluation
one can conclude that this possibility will be exploited.
Investigator's Summary
The results show that with the help of the ES 600,
analytical quality in terms of precision and reliability
can be achieved in the field of immunochemistry
which is comparable to the state of the art in clinical
chemistry. It is hence possible to carry out immu-
noassays with Enzyinun^Test® diagnostics as single
determinations on the ES 600 instrument without loss
of accuracy and precision.
The multicentre study was carried out with instru-
ments from the first production series. As a result of
this early period in the development of the instrument,
it became obvious during the evaluation that modi-
fications were necessary, although no basic changes
to the instrument concept were required for the pro-
duction series. The alterations can be summarized into
two areas:
Follow-Up Measurement Programme
After instrument modifications, a follow-up measur-
ing programme was carried out in four laboratories
in order to check the improvement in instrument
reliability. For this purpose, measurements aimed at
determining the within-series and between-series pre-
cisions were generally carried out using control sera
(Precinorm® IM and Precipath® IM) together with
human serum pools.
The results are summarized in tables 11 and 12. Par-
ticularly for the between-series precision (tab. 12),
lower coefficients of variation were found. These val-
ues are as a rule well below 10%; for the medium
concentration range the coefficients of variation were
generally found to be below 5%. In addition the
reliability of the instrument was clearly improved.
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Tab. 11. Withhvseries precision.
Recovery after instrument modification.
Enzymun-Test® Preci-
T4
N
Concentration
CV (%)
TBG
N
Concentration
CV (%)
Digoxin
N
Concentration
CV (%)
CEA
N
Concentration
CV (%)
TSH
N
Concentration
CV (%)
norm®-
IM
20
fog/d) 8.6
3.9
20
(mg/1) 16.0
2.4
20
Qig/O 1-08
3.5
20
( g/l) 6.2
1.5
, . 20
(mU/1) 3.1
1.8
Preci-
path®-
IM
20
16.0
3.9
20
36.7
1.5
20
3.62
2.0
20
54.9
1.0
20
6.4
1.3
Human
serum 1
20
5.2
5.1
20
7.8
3.4
20
0.99
4.0
20
4.0
1.5
20
1.9
3.3
Human
serum 2
20
11.8
3.8
20
19.0
2.4
20
2.72
2.0
20
32.9
1.5
20
13.1
1.6
Tab. 12. Between-series precision.
Repetition of measurements
cation.
Enzymun-Test®
T4
N
Concentration fag/dl)
CV (%)
TBG
N
Concentration (mg/1)
CV (%)
Digoxin
N
Concentration ftig/l)
CV (%)
CEA
N
Concentration fag/l)
CV (%)
TSH
N
Concentration (mU/1)
CV (%)
Precinorin®-
IM
10
7.4
3.4
9
16.9
6.6
10
1.04
5.9
10
6.4
4.6
9
3.7
12.1
after instrument modifi-
Precipath®-
IM
• r
10
18.7
5.7
9
34.7
4.1
10
3.61
4.0
10
55.5
3.3
9
6.3
6.0
Human
serum
10
6.1
3.3
9
8.8
11.4
10
1.28
5.5
10
4.2
2.7
9
8.2
2.8
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